Logo image of MAGN

MAGNERA CORP (MAGN) Stock Fundamental Analysis

USA - NYSE:MAGN - US55939A1079 - Common Stock

8.9 USD
-0.1 (-1.11%)
Last: 11/11/2025, 8:23:29 PM
8.9 USD
0 (0%)
After Hours: 11/11/2025, 8:23:29 PM
Fundamental Rating

3

Taking everything into account, MAGN scores 3 out of 10 in our fundamental rating. MAGN was compared to 9 industry peers in the Paper & Forest Products industry. MAGN may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, MAGN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MAGN had negative earnings in the past year.
MAGN had a negative operating cash flow in the past year.
In multiple years MAGN reported negative net income over the last 5 years.
In multiple years MAGN reported negative operating cash flow during the last 5 years.
MAGN Yearly Net Income VS EBIT VS OCF VS FCFMAGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

The Return On Assets of MAGN (-3.26%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -11.87%, MAGN is doing worse than 66.67% of the companies in the same industry.
MAGN has a better Return On Invested Capital (1.50%) than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MAGN is below the industry average of 5.72%.
The 3 year average ROIC (1.30%) for MAGN is below the current ROIC(1.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROIC 1.5%
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.3%
ROIC(5y)2.28%
MAGN Yearly ROA, ROE, ROICMAGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60

1.3 Margins

MAGN's Operating Margin of 2.48% is fine compared to the rest of the industry. MAGN outperforms 66.67% of its industry peers.
MAGN's Operating Margin has declined in the last couple of years.
MAGN has a Gross Margin (10.55%) which is in line with its industry peers.
MAGN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.48%
PM (TTM) N/A
GM 10.55%
OM growth 3Y-34.88%
OM growth 5Y-7.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.59%
GM growth 5Y-9.06%
MAGN Yearly Profit, Operating, Gross MarginsMAGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 -20

2

2. Health

2.1 Basic Checks

MAGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MAGN has more shares outstanding
The number of shares outstanding for MAGN has been increased compared to 5 years ago.
MAGN has a worse debt/assets ratio than last year.
MAGN Yearly Shares OutstandingMAGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
MAGN Yearly Total Debt VS Total AssetsMAGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that MAGN is in the distress zone and has some risk of bankruptcy.
MAGN has a Altman-Z score of 1.00. This is amonst the worse of the industry: MAGN underperforms 88.89% of its industry peers.
A Debt/Equity ratio of 1.76 is on the high side and indicates that MAGN has dependencies on debt financing.
MAGN has a Debt to Equity ratio of 1.76. This is in the lower half of the industry: MAGN underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Altman-Z 1
ROIC/WACC0.21
WACC7.23%
MAGN Yearly LT Debt VS Equity VS FCFMAGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

MAGN has a Current Ratio of 2.54. This indicates that MAGN is financially healthy and has no problem in meeting its short term obligations.
MAGN's Current ratio of 2.54 is fine compared to the rest of the industry. MAGN outperforms 66.67% of its industry peers.
MAGN has a Quick Ratio of 1.63. This is a normal value and indicates that MAGN is financially healthy and should not expect problems in meeting its short term obligations.
MAGN's Quick ratio of 1.63 is fine compared to the rest of the industry. MAGN outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.63
MAGN Yearly Current Assets VS Current LiabilitesMAGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

The earnings per share for MAGN have decreased strongly by -93.18% in the last year.
Looking at the last year, MAGN shows a decrease in Revenue. The Revenue has decreased by -7.10% in the last year.
MAGN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.85% yearly.
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.1%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%

3.2 Future

Based on estimates for the next years, MAGN will show a very strong growth in Earnings Per Share. The EPS will grow by 36.03% on average per year.
MAGN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.49% yearly.
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y41.51%
EPS Next 5Y36.03%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y17.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MAGN Yearly Revenue VS EstimatesMAGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
MAGN Yearly EPS VS EstimatesMAGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAGN. In the last year negative earnings were reported.
Also next year MAGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAGN Price Earnings VS Forward Price EarningsMAGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MAGN.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.93
MAGN Per share dataMAGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as MAGN's earnings are expected to grow with 41.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.28%
EPS Next 3Y41.51%

0

5. Dividend

5.1 Amount

MAGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAGNERA CORP

NYSE:MAGN (11/11/2025, 8:23:29 PM)

After market: 8.9 0 (0%)

8.9

-0.1 (-1.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)01-07 2026-01-07
Inst Owners101.93%
Inst Owner Change0.17%
Ins Owners0.54%
Ins Owner Change52.07%
Market Cap316.84M
Revenue(TTM)1.39B
Net Income(TTM)-134.25M
Analysts45.71
Price Target13.26 (48.99%)
Short Float %11.83%
Short Ratio5.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-4.06%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.14%
PT rev (3m)-7.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 1.63
EV/EBITDA 7.93
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.39
FCFYN/A
OCF(TTM)-0.85
OCFYN/A
SpS75.76
BVpS31.77
TBVpS5.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.26%
ROE -11.87%
ROCE 1.9%
ROIC 1.5%
ROICexc 1.63%
ROICexgc 2.29%
OM 2.48%
PM (TTM) N/A
GM 10.55%
FCFM N/A
ROA(3y)-5.49%
ROA(5y)-3.3%
ROE(3y)-30.19%
ROE(5y)-18.15%
ROIC(3y)1.3%
ROIC(5y)2.28%
ROICexc(3y)1.4%
ROICexc(5y)2.53%
ROICexgc(3y)1.78%
ROICexgc(5y)3.33%
ROCE(3y)1.65%
ROCE(5y)2.9%
ROICexgc growth 3Y-33.95%
ROICexgc growth 5Y-5.66%
ROICexc growth 3Y-31.5%
ROICexc growth 5Y-3.63%
OM growth 3Y-34.88%
OM growth 5Y-7.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.59%
GM growth 5Y-9.06%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.76
Debt/FCF N/A
Debt/EBITDA 7.73
Cap/Depr 28.75%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 1.63
Altman-Z 1
F-Score4
WACC7.23%
ROIC/WACC0.21
Cap/Depr(3y)52.95%
Cap/Depr(5y)52.64%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-14%
EPS Next 2Y16.28%
EPS Next 3Y41.51%
EPS Next 5Y36.03%
Revenue 1Y (TTM)-7.1%
Revenue growth 3Y14.77%
Revenue growth 5Y9.85%
Sales Q2Q%152.63%
Revenue Next Year120.68%
Revenue Next 2Y41.92%
Revenue Next 3Y28.37%
Revenue Next 5Y17.49%
EBIT growth 1Y117.27%
EBIT growth 3Y-25.26%
EBIT growth 5Y1.33%
EBIT Next Year515.25%
EBIT Next 3Y84.42%
EBIT Next 5Y46.73%
FCF growth 1Y-62.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-176.91%
OCF growth 3YN/A
OCF growth 5YN/A

MAGNERA CORP / MAGN FAQ

What is the fundamental rating for MAGN stock?

ChartMill assigns a fundamental rating of 3 / 10 to MAGN.


What is the valuation status of MAGNERA CORP (MAGN) stock?

ChartMill assigns a valuation rating of 1 / 10 to MAGNERA CORP (MAGN). This can be considered as Overvalued.


How profitable is MAGNERA CORP (MAGN) stock?

MAGNERA CORP (MAGN) has a profitability rating of 3 / 10.


What is the earnings growth outlook for MAGNERA CORP?

The Earnings per Share (EPS) of MAGNERA CORP (MAGN) is expected to decline by -14% in the next year.


How sustainable is the dividend of MAGNERA CORP (MAGN) stock?

The dividend rating of MAGNERA CORP (MAGN) is 0 / 10 and the dividend payout ratio is 0%.